Solarek et al. [135] provided evidence that in RCC, IGF signalling is mostly associated with circulating ligand proteins—IGF1 and IGF2, obtained from sources other than RCC cells themselves. The gene discussed is IGF2; the disease is renal cell adenocarcinoma.